GlassScriptPhysician profile
Taralyn Johnson
NPI 1730784745
$4,410.86
in general payments reported to CMS, 2019-2025
35 companies · $988 in 2025
The $988 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2023: $1,658 · 2024: $1,641 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,471 · Travel and Lodging: $785 · Education: $31.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,471.23 |
| Travel and Lodging | $784.97 |
| Education | $31.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,240.15 | 2023-2024 | Axonics |
| Procept Biorobotics Corporation | $481.79 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Sumitomo Pharma America, INC. | $342.17 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $299.06 | 2024-2025 | Xyosted, Tlando |
| Myriad Genetic Laboratories, INC. | $211.12 | 2023-2025 | Prolaris |
| Janssen Biotech, INC. | $169.43 | 2023-2025 | Erleada, Akeega, Balversa |
| Dendreon Pharmaceuticals LLC | $147.72 | 2024-2025 | Provenge |
| Abbvie INC. | $135.08 | 2024-2025 | |
| Accord Healthcare, INC. | $115.62 | 2023-2025 | |
| Astellas Pharma Global Development | $106.13 | 2025 | Xtandi |
| Endo USA, INC. | $105.52 | 2024-2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $103.94 | 2024-2025 | |
| Pfizer INC. | $89.25 | 2022-2025 | |
| 180 Medical, INC. | $88.42 | 2023-2024 | Gentlecath Glide, Gentlecath |
| Halozyme INC | $87.32 | 2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $83.81 | 2023-2025 | |
| Immunitybio, INC. | $68.01 | 2024-2025 | |
| Novo Nordisk INC | $66.64 | 2022-2023 | Ozempic, Rybelsus |
| Bluewind Medical | $58.66 | 2024-2025 | |
| Coloplast Corp | $51.68 | 2024 | |
| Endo Pharmaceuticals INC. | $46.24 | 2023 | Aveed, Xiaflex |
| Glaxosmithkline, LLC. | $42.18 | 2022 | |
| Astellas Pharma US INC | $33.99 | 2024 | Myrbetriq |
| C. R. Bard, INC. & Subsidiaries | $33.71 | 2025 | Bard Urinary Drainage Bag |
| Progenics Pharmaceuticals, INC. | $25.41 | 2024 | |
| Abc Home Medical Supply, INC. | $22.01 | 2025 | |
| Janssen Pharmaceuticals, INC | $20.60 | 2023 | Xarelto |
| Mimedx Group, INC. | $19.63 | 2024 | |
| Lilly USA, LLC | $19.59 | 2022 | |
| Merck Sharp & Dohme LLC | $18.75 | 2025 | Keytruda Qlex, Keytruda |
| Medtronic, INC. | $18.58 | 2025 | Interstim |
| Teleflex LLC | $18.09 | 2024 | Solesta |
| Exact Sciences Corporation | $15.07 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $14.93 | 2024 | Lynparza |
| Laborie Medical Technologies Corp. | $10.56 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taralyn Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.